Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Poloxamer 188

EU orphan designation number: EU/3/13/1112   
Active ingredient: Poloxamer 188
Indication: Treatment of sickle cell disease
Sponsor: Theradex (Europe) Ltd.
2nd Floor, The Pinnacle, Station Way, Crawley, West Sussex RH10 1JH, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/03/2013 Centralised Orphan - Designation EMA/OD/162/12 (2013)1606 of 12/03/2013
08/07/2014 Centralised Orphan - Change of address